In patients evaluable for the primary objective, the associations between the fraction of tumor-associated TCR clonal expansion at day 21 and pre-treatment PD-L1 positivity in immune cells and in tumor cells were explored by Spearman rank correlation coefficient tests. The gene discussed is CD274; the disease is neoplasm.